29.11.2012
- Abbott Laboratories said on Wednesday that its board approved the planned split of its branded pharmaceuticals business into a separate company and that Abbott investors would...
17.10.2012
- Abbott Laboratories reported mixed quarterly results, with earnings topping estimates but sales missing expectations as growth slowed for its Humira arthritis drug and other...
28.09.2012
- Abbott Laboratories for years misstated that the executive handpicked to head its pending pharmaceutical spinoff held both bachelor's and master's degrees, but on Thursday called...
18.07.2012
- Abbott Laboratories reported quarterly earnings roughly in line with Wall Street expectations and stuck to its 2012 profit view despite the harsh effects of the stronger dollar, in...
